NYSE-listed Covidien to enter Indian Healthcare Market

NYSE-listed Covidien to enter Indian Healthcare Market Covidien, a $10 billion global healthcare products leader, has announced its entry into the Indian healthcare market with the establishment of its headquarters at Gurgaon.

The company intends to collaborate with the region's healthcare providers to offer its cutting-edge medical solutions and services throughout the country.

According to sources, Covidien will setup three 'dry labs' this year to initiate training programmes for medical practitioners in the country. In addition, it will also introduce some of its patented products in India.

Covidien, formerly known as Tyco Healthcare, engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings worldwide.

The company operates through four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products, and Medical Supplies. Its customers include hospitals, surgi-centers, imaging centers, alternate site facilities, drug manufacturers, and retailers.